The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2025 for Raksha Sudhir Valia
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raksha Sudhir Valia, a Person Acting in Concert with the promoters of Sun Pharmaceutical Industries, has created a pledge on 6,50,000 equity shares (about 0.027% of total share capital) on July 28, 2025. The pledge is in favor of Citicorp Finance (India) Limited as security for a loan facility availed by a third party. Post this pledge, Raksha Valia's encumbered shares rise from 11,990,000 (0.499%) to 12,640,000 (0.527%) of total share capital. Her total holding in Sun Pharma stands at 28,830,352 shares (1.20%). This is a routine regulatory disclosure required when promoters or PACs create encumbrances on their shares.
Minimal impact on shareholders — the pledged quantity is very small (0.027% of total capital) and the pledge is for a third-party loan, not for the company itself. The overall promoter/PAC group remains well above 50% in Sun Pharma, so no change in control concerns arise.